Mark Groves
Impact in
- Neurology top 5%
- Neurological disorders and treatments
- Parkinson's Disease Mechanisms and Treatments
- Neurology and Historical Studies
- Botulinum Toxin and Related Neurological Disorders
-
- Genetic Neurodegenerative Diseases
Papers in ⓘ
-
- Genetic Neurodegenerative Diseases 11
- Neurology 10
- Neurological disorders and treatments 9
- Parkinson's Disease Mechanisms and Treatments 3
- Botulinum Toxin and Related Neurological Disorders 1
- Co-authors
- David Craufurd (5 shared papers)Karen E. Anderson (5 shared papers)Daniël P. van Kammen (4 shared papers)Erik van Duijn (3 shared papers)Nathan Goodman (2 shared papers)Mary Edmondson (2 shared papers)LaVonne Goodman (2 shared papers)Christina A Palmese (2 shared papers)
- Journals
- PLoS Currents (4 papers)Journal of Neuropsychiatry (2 papers)Journal of Psychiatric Research (1 paper)Current Neurology and Neuroscience Reports (1 paper)Journal of Huntington s Disease (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Mark Groves
14 papers receiving 280 citations
Peers
Comparison fields: 5 of 38
- Neurology 224
- Cellular and Molecular Neuroscience 221
- Neurology 35
- Psychiatry and Mental health 37
- Molecular Biology 86
Countries citing papers authored by Mark Groves
This map shows the geographic impact of Mark Groves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Groves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Groves more than expected).
Fields of papers citing papers by Mark Groves
This network shows the impact of papers produced by Mark Groves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Groves. The network helps show where Mark Groves may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Groves, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 80 | |
| 2 | 2013 | 51 | |
| 3 | 2011 | 42 | |
| 4 | 2011 | 33 | |
| 5 | 2016 | 24 | |
| 6 | 2016 | 16 | |
| 7 | 2011 | 11 | |
| 8 | 2004 | 10 | |
| 9 | Parkinson's disease as a model for psychosocial issues in chronic neurodegenerative disease. | 2005 | 5 |
| 10 | 2015 | 5 | |
| 11 | 2011 | 5 | |
| 12 | 2017 | 2 | |
| 13 | 2003 | 1 | |
| 14 | 2004 | 1 |
About Mark Groves
Mark Groves is a scholar working on Cellular and Molecular Neuroscience, Neurology, Clinical Psychology, Cognitive Neuroscience and Psychiatry and Mental health, having authored 14 papers that have together received 286 indexed citations. Recurring topics across this work include Genetic Neurodegenerative Diseases (11 papers), Neurological disorders and treatments (9 papers), Parkinson's Disease Mechanisms and Treatments (3 papers), Attention Deficit Hyperactivity Disorder (2 papers), Obsessive-Compulsive Spectrum Disorders (2 papers), Autism Spectrum Disorder Research (2 papers), Mental Health and Psychiatry (1 paper) and Botulinum Toxin and Related Neurological Disorders (1 paper). The work is most often cited by research in Neurology (224 citations), Cellular and Molecular Neuroscience (221 citations), Neurology (35 citations), Psychiatry and Mental health (37 citations) and Molecular Biology (86 citations). Mark Groves has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include David Craufurd, Karen E. Anderson, Daniël P. van Kammen, Erik van Duijn, Nathan Goodman, Mary Edmondson, LaVonne Goodman, Christina A Palmese, Vicki Shanker and Jane S. Paulsen. Their work appears in journals such as PLoS Currents, Journal of Neuropsychiatry, Journal of Psychiatric Research, Current Neurology and Neuroscience Reports and Journal of Huntington s Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.